Ivelina M.
- Country
- Bulgaria
- Department
- NA
Research Overview
Data & Insights
Has run more than one trial at 6 of 212 partner sites.
Specializations
Cardiovascular disease and atrial fibrillation
Ivelina Mihaleva is involved in clinical research focused on cardiovascular risk reduction, atrial fibrillation, and prevention of major thromboembolic and ischemic events in patients with established or high-risk cardiovascular profiles.
- Stroke prevention in atrial fibrillation
- High cardiovascular risk
- Established cardiovascular disease
The investigator’s work also extends to therapies aimed at reducing coronary and systemic vascular complications in patients without prior myocardial infarction or stroke.
Heart failure and hypertension
Her clinical trial activity includes heart failure across preserved and reduced ejection fraction phenotypes, as well as difficult-to-control hypertension and resistant blood pressure elevation.
- HFpEF and HFmrEF
- Heart failure prevention
- Resistant hypertension
She is also engaged in research on blood pressure-lowering strategies designed to lower cardiovascular event risk in patients with elevated cardiometabolic burden.
Chronic kidney disease and albuminuria
Ivelina Mihaleva contributes to studies in chronic kidney disease, including populations with albuminuria and high proteinuria, where renal protection and slowing kidney function decline are central therapeutic goals.
- Chronic kidney disease and hypertension
- Albuminuria
- High proteinuria
Her research interest includes kidney-focused interventions linked to cardiovascular protection and long-term renal preservation.
Lipid disorders and hypertriglyceridemia
Her trial portfolio includes treatment areas centered on hypertriglyceridemia, severe hypertriglyceridemia, and broader lipid management in patients with elevated atherogenic risk.
- Severe hypertriglyceridemia
- Elevated lipoprotein(a)
- Lipid-lowering therapy
This activity reflects a therapeutic focus on reducing residual cardiovascular risk through lipid-modifying approaches.
Endocrine and neurologic disorders
She is also involved in research on Graves’ disease, Tourette’s disorder, and insomnia disorder, indicating engagement with endocrine, neuropsychiatric, and sleep-related therapeutic areas.
- Graves’ disease
- Tourette’s disorder
- Insomnia disorder
These studies broaden her clinical research landscape beyond cardiometabolic disease into disorders requiring targeted symptom control and long-term disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.